What Adaptogens Actually Are (and What They Aren't)

Where the term came from

The word was coined in the Soviet Union in the mid-twentieth century by pharmacologist Nikolai Lazarev and developed further by Israel Brekhman. It described substances proposed to increase non-specific resistance to physical, chemical and biological stressors.

The original criteria were reasonably strict: non-toxic at normal doses, producing a non-specific response, and having a normalising effect regardless of the direction the body had drifted.

Which botanicals are usually included

• Ashwagandha — the most researched of the group
• Rhodiola rosea — studied mainly around mental fatigue
• Panax ginseng — the longest commercial history
• Eleuthero — Brekhman's original subject
• Holy basil, schisandra and others — with weaker supporting data

What the evidence supports

Some adaptogens, ashwagandha in particular, have randomised human trials examining stress-related measures. Most have far less. The category label does not confer evidence on every member.

“Adaptogen” is a proposed mechanism class, not a proof of effect. A product describing itself as adaptogenic has told you what it is trying to do, not that it succeeds.

How the word gets misused

• Applied to any plant with vaguely calming associations
• Used to imply pharmaceutical-grade evidence where only traditional use exists
• Presented as if “balances your body” were a measurable demonstrated outcome

The practical takeaway

Treat the word as a description of intent, then check the specific ingredient against a neutral source such as NCCIH Herbs at a Glance.

Keep reading

• Zinc, Magnesium and Testosterone: What the Claims Really Say
• Ashwagandha for Men: What the Research Shows
• Bacopa Monnieri: The Memory Evidence Examined
• Ginkgo Biloba: What the Evidence Actually Says
• Rhodiola Rosea and Mental Fatigue

Found this useful? The rest of the series is on the Horsewood blog.